Crossmark

Using CombiCells, a platform for titration and combinatorial display of cell surface ligands, to study T-cell antigen sensitivity modulation by accessory receptors

Crossref DOI link: https://doi.org/10.1038/s44318-023-00012-1

Published Online: 2023-12-18

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Patel, Ashna https://orcid.org/0009-0008-4502-3990
Andre, Violaine

Eguiguren, Sofia Bustamante

Barton, Michael I https://orcid.org/0000-0002-9263-6481
Burton, Jake

Denham, Eleanor M

Pettmann, Johannes

Mørch, Alexander M https://orcid.org/0000-0002-1881-2424
Kutuzov, Mikhail A https://orcid.org/0000-0003-3386-4350
Siller-Farfán, Jesús A

Dustin, Michael L https://orcid.org/0000-0003-4983-6389
van der Merwe, P Anton https://orcid.org/0000-0001-9902-6590
Dushek, Omer https://orcid.org/0000-0001-5847-5226
Funding

Funding for this research was provided by:

Wellcome Trust (207537/Z/17/Z)

Wellcome Trust ((108869/Z/15/Z)

UKRI | Biotechnology and Biological Sciences Research Council ((BB/M011224/1)

Kennedy Trust for Rheumatology Research
License Information

Text and Data Mining valid from 2023-12-18

Version of Record valid from 2023-12-18
More Information

Article History

Received: 25 August 2023

Revised: 5 November 2023

Accepted: 10 November 2023

First Online: 18 December 2023

Disclosure and competing interests statement

: AP, ED, JP, PAvdM, and OD have financial interests in a filed patent application related to CombiCells.

Document is current

Any future updates will be listed below